이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Boill Healthcare Holdings 대차 대조표 상태

재무 상태 기준 확인 0/6

Boill Healthcare Holdings 의 총 주주 지분은 HK$63.0M 이고 총 부채는 HK$850.7M, 이는 부채 대 자기자본 비율을 1349.5% 로 가져옵니다. 총자산과 총부채는 각각 HK$1.4B 및 HK$1.4B 입니다.

주요 정보

-253.0%

부채 비율

HK$842.18m

부채

이자 보상 비율	n/a
현금	HK$1.08m
주식	-HK$332.90m
총 부채	HK$1.63b
총 자산	HK$1.30b

최근 재무 상태 업데이트

Boill Healthcare Holdings (HKG:1246) Has Debt But No Earnings; Should You Worry?

Jul 31

Recent updates

Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 89% Share Price Slump

Jun 03

The Price Is Right For Boill Healthcare Holdings Limited (HKG:1246) Even After Diving 26%

Apr 18

Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 33% Share Price Slump

Feb 05

Boill Healthcare Holdings (HKG:1246) Has Debt But No Earnings; Should You Worry?

Jul 31

Lacklustre Performance Is Driving Boill Healthcare Holdings Limited's (HKG:1246) Low P/S

Apr 18

There's Been No Shortage Of Growth Recently For Boill Healthcare Holdings' (HKG:1246) Returns On Capital

Jul 22

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Jul 13

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Mar 21

Have Insiders Been Buying Boill Healthcare Holdings Limited (HKG:1246) Shares This Year?

Jan 27

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Dec 05

재무 상태 분석

단기부채: 1246 에는 음의 주주 지분이 있는데, 이는 단기 부채를 감당하지 못하는 단기 자산보다 더 심각한 상황입니다.

장기 부채: 1246 의 주주 지분은 음수입니다. 이는 장기 부채를 감당하지 못하는 단기 자산보다 더 심각한 상황입니다.

부채 대 자본 내역 및 분석

부채 수준: 1246 은 부정주주자본을 갖고 있는데, 이는 높은 부채 수준보다 더 심각한 상황입니다.

부채 감소: 1246 의 주주 지분은 음수이므로 시간이 지남에 따라 부채가 감소했는지 확인할 필요가 없습니다.

대차 대조표

현금 런웨이 분석

과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.

안정적인 현금 활주로: 1246 의 현재 여유 현금 흐름을 기준으로 충분한 현금 활주로가 있는지 판단하기에는 데이터가 부족합니다.

예측 현금 활주로: 1246 의 여유 현금 흐름이 역사적 비율에 따라 계속 증가하거나 감소하는 경우 충분한 현금 활주로가 있는지 판단하기에는 데이터가 부족합니다.

Boill Healthcare Holdings 대차 대조표 상태

재무 상태 기준 확인 0/6

주요 정보

최근 재무 상태 업데이트

Boill Healthcare Holdings (HKG:1246) Has Debt But No Earnings; Should You Worry?

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Recent updates

Boill Healthcare Holdings Limited Announces Board Changes

Boill Healthcare Holdings Limited Announces Removal of Yuen Wai Keung as Company Secretary

Boill Healthcare Holdings Limited Announces Change of Directors and Change in Composition of Board Committees

Boill Healthcare Holdings Limited, Annual General Meeting, Sep 26, 2024

Full year 2024 earnings released: HK$0.087 loss per share (vs HK$0.17 loss in FY 2023)

Boill Healthcare Holdings Limited to Report Fiscal Year 2024 Results on Jun 28, 2024

Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 89% Share Price Slump

New major risk - Market cap size

Boill Healthcare Holdings Limited Announces Company Secretary Changes

The Price Is Right For Boill Healthcare Holdings Limited (HKG:1246) Even After Diving 26%

Boill Healthcare Holdings Limited Announces Resignation of Qiu Bin as an Executive Director

Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 33% Share Price Slump

Boill Healthcare Holdings Limited Announces Board Changes, Effective from January 27, 2024

Boill Healthcare Holdings Limited Announces Change of Company Secretary Andauthorised Representative Andappointment of Process Agent

First half 2024 earnings released

Boill Healthcare Holdings Limited to Report Q2, 2024 Results on Nov 24, 2023

Boill Healthcare Holdings Limited Announces Executive Changes

Boill Healthcare Holdings (HKG:1246) Has Debt But No Earnings; Should You Worry?

Full year 2023 earnings released: HK$0.17 loss per share (vs HK$0.009 loss in FY 2022)

New major risk - Market cap size

Boill Healthcare Holdings Limited, Annual General Meeting, Sep 27, 2023

Full year 2023 earnings released

New minor risk - Financial data availability

Boill Healthcare Holdings Limited to Report Fiscal Year 2023 Results on Jun 28, 2023

Lacklustre Performance Is Driving Boill Healthcare Holdings Limited's (HKG:1246) Low P/S

First half 2023 earnings released: HK$0.071 loss per share (vs HK$0.007 loss in 1H 2022)

Boill Healthcare Holdings Limited to Report First Half, 2023 Results on Nov 30, 2022

Less than half of directors are independent

Boill Healthcare Holdings Limited Approves Appointment of Directors

Full year 2022 earnings released: HK$0.38 loss per share (vs HK$0.13 loss in FY 2021)

Boill Healthcare Holdings Limited, Annual General Meeting, Sep 09, 2022

Boill Healthcare Holdings Limited Announces Board Retirements

There's Been No Shortage Of Growth Recently For Boill Healthcare Holdings' (HKG:1246) Returns On Capital

Full year 2022 earnings released: HK$0.38 loss per share (vs HK$0.13 loss in FY 2021)

Boill Healthcare Holdings Limited Provides Group Earning Guidance for the Financial Year Ended 31 March 2022

Boill Healthcare Holdings Limited to Report Fiscal Year 2022 Results on Jun 30, 2022

Insufficient new directors

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Full year 2021 earnings released: HK$0.13 loss per share (vs HK$0.21 loss in FY 2020)

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Have Insiders Been Buying Boill Healthcare Holdings Limited (HKG:1246) Shares This Year?

New 90-day low: HK$0.22

First half 2021 earnings released: HK$0.078 loss per share

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

First half 2021 earnings released: HK$0.078 loss per share

Boill Healthcare Holdings Limited to Report First Half, 2021 Results on Nov 27, 2020

New 90-day low: HK$0.26

재무 상태 분석

부채 대 자본 내역 및 분석

대차 대조표

현금 런웨이 분석

건강한 기업 발견하기